+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artemisinic Acid Market Size, Share & Trends Analysis Report By Type (Antimalarial Injections, Antimalarial Tablets), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • April 2023
  • Region: Global
  • Grand View Research
  • ID: 5786701
Description Jump to:
The global artemisinic acid market size is expected to reach USD 975.05 million by 2030, expanding at 4.24% CAGR from 2023 to 2030. This growth can be attributed to the high burden of malaria in underdeveloped and developing economies, a large number of research studies concerning Malaria, and initiatives by public organizations such as the WHO, UNICEF, and others. These organizations are committed to controlling the incidences of malaria globally by creating awareness about malaria treatment.

Developing and underdeveloped economies suffer from a high burden of malaria. For instance, as per UNICEF, malaria is a major cause of death among children in Africa. The WHO states that 95% of total malaria cases were reported in Africa region. The high burden of diseases in this region is expected to boost the demand for artemisinic acid, especially in these regions, and thus boost the market.

Public organizations globally are trying to reduce the incidence of malaria by improving access to detection, treatment, and prevention of the disease. Moreover, organizations such as WHO, UNICEF. The government organization are actively involved in raising awareness about malaria treatment to reduce the spread of the infection. This is expected to improve the demand for artemisinic acid during the forecast period.

The Global Fund states that there was a fall in malaria diagnosis and treatment in 2020 as compared to the previous year. This is because the majority of diagnosis was done for testing COVID-19. This initially hampered the market of artemisinic acid. However, World Malaria Report states that malaria incidences totaled 247 million in 2021, whereas in 2020. The figure stood at 245 million. The increase in the incidence of malaria is expected to boost the demand for malaria treatments and boost the market in the post-pandemic period.

Artemisinic Acid Market Report Highlights

  • The antimalarial tablet segment is expected to grow at the fastest rate of 4.26% CAGR, owing to the high preference for tablet formulation as it provides ease of administration and does not rely on professional assistance
  • Asia Pacific region is expected to grow at a rate of 4.13% CAGR over the forecast owing to the surge in the number of initiatives by the public organization to increase awareness about malaria treatments
  • MEA region held the largest share of 56.89% in 2022, owing to the high burden of malaria in the region, thus contributing to the demand for treatment

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Volume price analysis (Model 2)
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
1.9.3. Objective 3
1.9.4. Objective 4
Chapter 2. Executive Summary
2.1. Market Outlook
Chapter 3. Artemisinic Acid Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. High prevalence of Malaria
3.3.1.2. Initiatives by public organizations to improve access to malaria treatment
3.3.1.3. High adoption of Artemisinin-based combination therapies (ACT)
3.3.2. Market restraint analysis
3.3.2.1. Drug resistance with Artemisinin-based combination therapies (ACT)
3.3.2.2. Availability of Substitutes
3.3.3. Covid-19 Impact & Recovery Analysis
3.3.4. Industry Analysis - Porter’s
3.3.5. PESTLE Analysis
Chapter 4. Artemisinic Acid Market: Type Segment Analysis
4.1. Artemisinic Acid Market: Definition & Scope
4.2. Artemisinic Acid Market: Product Market Share Analysis, 2022 & 2030
4.3. Antimalarial Injections
4.3.1. Antimalarial Injections Market, 2018 - 2030 (USD Million)
4.4. Antimalarial Tablets
4.4.1. Antimalarial Tablets Market, 2018 - 2030 (USD Million)
Chapter 5. Artemisinic Acid Market: Regional Analysis
5.1. Artemisinic Acid Regional market share analysis, 2022 & 2030
5.2. North America
5.2.1. North America Market estimates and forecast, 2018 - 2030
5.2.2. U.S.
5.2.2.1. U.S. Market estimates and forecast, 2018 - 2030
5.2.3. Canada
5.2.3.1. Canada Market estimates and forecast, 2018 - 2030
5.3. Europe
5.3.1. Europe Market estimates and forecast, 2018 - 2030
5.3.2. U.K.
5.3.2.1. U.K. Market estimates and forecast, 2018 - 2030
5.3.3. Germany
5.3.3.1. Germany Market estimates and forecast, 2018 - 2030
5.3.4. France
5.3.4.1. France Market estimates and forecast, 2018 - 2030
5.3.5. Italy
5.3.5.1. Italy Market estimates and forecast, 2018 - 2030
5.3.6. Spain
5.3.6.1. Spain Market estimates and forecast, 2018 - 2030
5.3.7. Denmark
5.3.7.1. Denmark Market estimates and forecast, 2018 - 2030
5.3.8. Sweden
5.3.8.1. Sweden Market estimates and forecast, 2018 - 2030
5.3.9. Norway
5.3.9.1. Norway Market estimates and forecast, 2018 - 2030
5.4. Asia Pacific
5.4.1. Asia Pacific Market estimates and forecast, 2018 - 2030
5.4.2. China
5.4.2.1. China Market estimates and forecast, 2018 - 2030
5.4.3. India
5.4.3.1. India Market estimates and forecast, 2018 - 2030
5.4.4. Japan
5.4.4.1. Japan Market estimates and forecast, 2018 - 2030
5.4.5. South Korea
5.4.5.1. South Korea Market estimates and forecast, 2018 - 2030
5.4.6. Thailand
5.4.6.1. Thailand Market estimates and forecast, 2018 - 2030
5.4.7. Australia
5.4.7.1. Australia Market estimates and forecast, 2018 - 2030
5.4.8. Pakistan
5.4.8.1. Pakistan Market estimates and forecast, 2018 - 2030
5.4.9. Indonesia
5.4.9.1. Indonesia Market estimates and forecast, 2018 - 2030
5.4.10. Vietnam
5.4.10.1. Vietnam Market estimates and forecast, 2018 - 2030
5.5. Central & South America
5.5.1. Central & South America Market estimates and forecast, 2018 - 2030
5.5.2. Brazil
5.5.2.1. Brazil Market estimates and forecast, 2018 - 2030
5.5.3. Mexico
5.5.3.1. Mexico Market estimates and forecast, 2018 - 2030
5.5.4. Argentina
5.5.4.1. Argentina Market estimates and forecast, 2018 - 2030
5.5.5. Colombia
5.5.5.1. Colombia Market estimates and forecast, 2018 - 2030
5.6. MEA
5.6.1. MEA Market estimates and forecast, 2018 - 2030
5.6.2. South Africa
5.6.2.1. South Africa Market estimates and forecast, 2018 - 2030
5.6.3. Saudi Arabia
5.6.3.1. Saudi Arabia Market estimates and forecast, 2018 - 2030
5.6.4. UAE
5.6.4.1. UAE Market estimates and forecast, 2018 - 2030
5.6.5. Kuwait
5.6.5.1. Kuwait Market estimates and forecast, 2018 - 2030
5.6.6. Nigeria
5.6.6.1. Nigeria Market estimates and forecast, 2018 - 2030
5.6.7. Democratic Republic of Congo
5.6.7.1. The Democratic Republic of Congo Market estimates and forecast, 2018 - 2030
5.6.8. Mali
5.6.8.1. Mali Market estimates and forecast, 2018 - 2030
5.6.9. Uganda
5.6.9.1. Uganda Market estimates and forecast, 2018 - 2030
5.6.10. Kenya
5.6.10.1. Kenya Market estimates and forecast, 2018 - 2030
Chapter 6. Competitive Analysis
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Participant Categorization
6.3. Heat-Map Analysis
6.3.1. Artemisinic Acid share analysis
Chapter 7. Competitive Landscape
7.1. Company Profiles
7.1.1. Sanofi
7.1.1.1. Company overview
7.1.1.2. Financial performance
7.1.1.3. Product benchmarking
7.1.1.4. Strategic initiatives
7.1.2. KPC Pharmaceuticals, Inc
7.1.2.1. Company overview
7.1.2.2. Financial performance
7.1.2.3. Product benchmarking
7.1.2.4. Strategic initiatives
7.1.3. Guilin Pharmaceutical Co., Ltd
7.1.3.1. Company overview
7.1.3.2. Financial performance
7.1.3.3. Product benchmarking
7.1.3.4. Strategic initiatives
7.1.4. Calyx Chemicals and Pharmaceuticals Ltd.
7.1.4.1. Company overview
7.1.4.2. Financial performance
7.1.4.3. Product benchmarking
7.1.4.4. Strategic initiatives
7.1.5. Novartis AG
7.1.5.1. Company overview
7.1.5.2. Financial performance
7.1.5.3. Product benchmarking
7.1.5.4. Strategic initiatives
7.1.6. .Ipca Laboratories Ltd
7.1.6.1. Company overview
7.1.6.2. Financial performance
7.1.6.3. Product benchmarking
7.1.6.4. Strategic initiatives
7.1.7. Cipla Inc.
7.1.7.1. Company overview
7.1.7.2. Financial performance
7.1.7.3. Product benchmarking
7.1.7.4. Strategic initiatives
7.1.8. Shin Poong Pharm Co., Ltd
7.1.8.1. Company overview
7.1.8.2. Financial performance
7.1.8.3. Product benchmarking
7.1.8.4. Strategic initiatives
7.1.9. Rupus Global Limited
7.1.9.1. Company overview
7.1.9.2. Financial performance
7.1.9.3. Product benchmarking
7.1.9.4. Strategic initiatives
7.1.10. AdvacarePharma
7.1.10.1. Company overview
7.1.10.2. Financial performance
7.1.10.3. Product benchmarking
7.1.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Artemisinic Acid Market, by Region, 2018 - 2030 (USD Million)
Table 4 North America Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 5 U.S. Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 6 Canada Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 7 Europe Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 8 U.K. Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 9 Germany Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 10 France Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 11 Italy Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 12 Spain Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 13 Denmark Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 14 Sweden Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 15 Asia Pacific Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 16 China Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 17 India Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 18 Japan Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 19 South Korea Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 20 Thailand Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 21 Australia Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 22 Pakistan Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 23 Indonesia Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 24 Vietnam Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 25 Central & South America Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 26 Brazil Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 27 Mexico Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 28 Argentina Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 29 Colombia Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 30 MEA Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 31 South Africa Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 33 UAE Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 34 Kuwait Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 35 Nigeria Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 36 Democratic Republic of Congo Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 37 Mali Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 38 Uganda Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
Table 39 Kenya Artemisinic Acid Market, by Type, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow analysis
Fig. 10 Volume price analysis
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook (2022)
Fig. 15 Porter’s five force analysis
Fig. 16 PESTLE Analysis
Fig. 17 Artemisinic Acid market: Type outlook & key takeaways
Fig. 18 Antimalarial Injections
Fig. 19 Antimalarial Tablets
Fig. 20 Regional marketplace: key takeaway
Fig. 21 Artemisinic Acid market: Regional movement analysis
Fig. 22 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Norway market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Pakistan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Indonesia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Vietnam market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Central & South America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Colombia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 MEA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Nigeria market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Democratic Republic of Congo market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Mali market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Uganda market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Kenya market estimates and forecast, 2018 - 2030 (USD Million)

Companies Mentioned

  • Sanofi
  • KPC Pharmaceuticals, Inc
  • Guilin Pharmaceutical Co., Ltd
  • Calyx Chemicals and Pharmaceuticals Ltd.
  • Novartis AG
  • Ipca Laboratories Ltd
  • Cipla Inc.
  • Shin Poong Pharm Co., Ltd
  • Rupus Global Limited
  • AdvacarePharma

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedApril 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 699.18 Million
Forecasted Market Value ( USD ) by 2030 $ 975.05 Million
Compound Annual Growth Rate4.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Antimalarial Drugs Market by Drug Class, Drug Type, Route of Administration, Malaria Type, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Antimalarial Drugs Market by Drug Class, Drug Type, Route of Administration, Malaria Type, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Anti-Malarial Medicines - Global Strategic Business Report - Product Image

Anti-Malarial Medicines - Global Strategic Business Report

  • Report
  • 288 Pages
  • Global
From
Anti-malarial Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Image

Anti-malarial Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • 255 Pages
  • Global
From
2024 Global Forecast for Antimalarials, Plasmodicides (2025-2030 Outlook) - Manufacturing & Markets Report - Product Image

2024 Global Forecast for Antimalarials, Plasmodicides (2025-2030 Outlook) - Manufacturing & Markets Report

  • Report
  • 132 Pages
  • Global
From
Anti-Malarial Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Anti-Malarial Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 102 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.